03-18 Metab Liver Dz Flashcards
• Discuss the clinical presentation including laboratory testing, and pathogenesis of the following conditions: Alpha 1 Antitrypsin Deficiency, Hereditary Hemochromatosis and Wilson's disease • Discuss the management of the above conditions • Describe glycogen storage diseases and their effect on the liver and selected other less common metabolic inherited liver diseases
OBJECTIVE: Clinical Presentation w/ labs of A1AT Deficiency; Acquired or Inherited?
Inherited, A.D. w/ co-dom expression (as common as CF; ~1% of COPD pts)
—only 10-15% of ZZ allelic individuals present w/ clinical dz
CLINICAL PRESENTATION: CHILD ≠ ADULT
Children: Liver > Lung
most common pedi liver dz
—Neonatal jaundice, hepatomegaly, failure to thrive, or acute liver failure
Adults: Lung > Liver
- Emphysema/COPE
- ZZ: 8X risk of cirrhosis, 20X risk of HCC
- SZ/MZ: heterozygotes w/ cirrhosis usually have another co-founding risk factor
- Lesson common:
- Necrotizing panniculitis- painful localized necrosis of subQ fat
- Anti-proteinase-3-positive vasculitis (painful bruising w/ serosanguinous weeping) [seen here]
LAB FINDINGS
- Low A1AT
- Protein geno- or phenotyping: MZ, SZ or ZZ A1AT alleles
- Consider bx to r/o other causes
CHILDREN: 25% w/ ↑ liver enzymes

OBJECTIVE: Pathogenesis of A1AT deficiency
A1AT Inhibits proteases, specifically neutrophil elastase released during inflammation
- 2 main organs involved w/ 2 very different Mechs
- Lung: Inability to inhibit neutrophil elastase leads to destruction of lung parenchyma → lung disease and COPD
- A1AT is responsible >90% of anti-elastase activity in alveolar lavage fluid
- Liver: Accumulation of aberrant folded A1AT protein in ER → apoptosis, mitochondrial injury, hepatic necrosis leading to fibrosis and cirrhosis
OBJECTIVE: Management of A1AT deficiency.
LIVER TX
- stop smoking (it makes liver dz worse, too)
- correct modifiable risk factors: wt, DM, HTN, etc.
- Liver transplant, PRN
- Experimental:
- Gene therapy
- Carbamezapine and Rifamycin
LUNG TX
- replace the A1AT w/ a functioning version to stop destruction of lung tissue by elastase
A1AT deficiency relatives
Other serine protease inhibitors
- C1 Inhibitor (hereditary angioedema)
- Antithrombin III (thrombosis)
- α1-antichymotrypsin (COPD)
Can be inherited with A1AT b/c close proximity on Chromosome 14
What are the 3 iron-regulating compounds? What are their fxns?
Hepcidin (hepatic bactericidal protein)
- Hormone produced in the liver that responds to serum iron levels
- Stimulates iron transportation into cells (M0s, enterocytes, hepatocytes)
- Binds ferroportin (iron exporter on M0s and basolateral enterocyte), internalizes it and targets it for degradation
- Acute phase reactant: ↑ in inflamm
Ferroportin
- Main iron export protein
- Found on enterocytes, hepatocytes, M0s
- Regulated by hepcidin binding
HFE protein
- HFE = Human hemochromatosis protein
- encoded by HFE gene
- Iron sensor found on hepatocytes

OBJECTIVE: Clinical presentation w/ labs of Hereditary Hemochromatosis; Acquired or Inherited?
CLINICAL PRESENTATION
- ♂ : ♀ = 8 : 1; Avg onset 40-50 y/o
- Most common s/sx:
- weakness, lethargy, arthralgias, abdominal pain, and ↓ libido or potency in ♂
- Exam:
- hepatosplenomegaly
- ascites, edema, and jaundice, may be present.
- Bronzed or slate-gray skin (Fe in basal epidermis)
- Other
- hypothyroid
- hypogonadotrophic hypogonadism
- cardiomyopathy, valvulopathy
- Arthropathy of 2nd/3rd MCPs w/ joint space narrowing, chondrocalcinosis, subchondral cyst formation, osteopenia, and swollen joints
- Infections in iron-loaded patients (Vibrio vulnificus, Listeria **monocytogenes, Yersinia enterocolitica, and Yersinia pseudotuberculosis)
LABS
- ↑ liver enzymes
- ↑ transferrin
- ↑ tranferrin sat
- ↑ iron index = age-adjusted serum Fe
- HFE genotype
- bad one = C282Y
- more minor = H63D
- (others S65C)
OBJECTIVE: Pathogenesis of Hereditary Hemochromatosis
- Mutation of hepatic Fe-sensor proteins (e.g. HFE)
- Hepatocytes “see” low iron → therefore they stop hepcidin synth
- ferroportin goes regulating pumping iron absorbed by enterocytes into the blood and allow its uptake by M0s, etc.
- Increased iron levels & transferrin saturation
- Deposition in the liver, heart, spleen and endocrine organs
OBJECTIVE: Management of Hereditary Hemochromatosis + Prognosis
- Routine phlebotomy
- If can’t tolerate: Rx = deferoxamine (iron-chelator)
- avoid Fe-rich food, Vit C (↑ absorption)
- avoid raw shellfish (vibrio risk)
Normal life span if tx’d before cirrhosis
- Arthritis, liver fibrosis, risk of HCC and hypogonadism do not improve, however
- Prognosis depends on genotype homozygous C282Y is the bad one RR of developing HCC = 120
OBJECTIVE: Clinical presentation w/ labs of Wilson’s disease
Kids - hepatic presentation
- Sx: fatigue, anorexia, or abdominal pain.
- High LFTs, hepatomegaly, fatty liver on bx
- Kayser-Fleischer rings (on slit lamp exam) [seen here]
Adults - neuro presentation
- movement: Tremors, ↓ coordination, + lose fine motor control
- rigid dystonia: Mask-like facies, rigidity, and gait disturbance + pseudobulbar (drool/dysarth) involvement
20% Have Pure Psychiatric Presentation
- Depression is common
- Phobias or compulsive behavior
- Aggressive or antisocial behavior
LAB FINDINGS
- ↑ 24hr urine Cu
- ↑ serum Cu
- ↓ ceruloplasmin

OBJECTIVE: Pathogenesis of Wilson’s disease
A.R. inherited disease of defective biliary Cu excretion protein ATP7B
- cannot excrete Cu into bile normally
- Cu builds up and accumulates in
- brain
- liver
- eyes
- heart
- kidneys

OBJECTIVE: Management of Wilson’s disease
Dietary
- eliminate copper-rich food such as organ meats, shellfish, nuts, chocolate, and mushrooms
- Analyze drinking water
Rx
- D- penicillamine = gold std
- Trientine - for neuro sx
- Zinc (maintenancy therapy)
- Liver transplant
- Genetic screening for family members
DDx for Kayser Fleischer Rings
Kayser-Fleischer rings are not specific for Wilson disease.
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
- Autoimmune Hepatitis
- or familial cholestatic syndromes.
OBJECTIVE: Describe glycogen storage diseases and their effect on the liver
Three types of glycogen storag disease
- GSD I = deficiency of glucose-6-phosphatase
- GSD III = amylo-1,6-glucosidase debranching enzyme
- GSD IV = Deficiency of the branching enzyme
Dx these w/ enzyme test on fresh liver tissue
Present w/ hepatomegaly, abd distention, hypoglycemia, failure to thrive, other liver-related things; subtle difference betwen them
Tx: low carb diet, give starch at night? transplant
Chart on slide 12
.
Crigler-Najjar vs. Dubin-Johnson and Rotor Syndrome
Crigler-Najjer Syndrome
- Children
- Defect in conjugation (glcuronyl transferease) of bilirubin
- Unconjugated hyperbilirubinemia
Dubin Johnson and Rotor Syndrome
- Defect in excretion of bilirubin
- Conjugated hyperbilirubinemia
Gilbert’s syndrome 101
defect in uptake of bilirubin
- cause Unconjugated Hyperbilirubinemia seen in 5% adults
- in fact not a disease but a groups of humans with a slower than normal (the other 95%) handling of bilirubin that under stress circumstances may lead to an isolated ↑ bilirubin
Tyrosinemia 101
defect of amino acid metabolism via deficiency of fumaryl acetoacetate hydrolase (FAH) associated with tyrosine degradation pathway
- Highly associated with Hepatocellular carcinoma
Gaucher’s Disease 101
defect in lipid metabolism via deficiency of glucocerebrosidase
Progressive familial intrahepatic cholestasis (PFIC) syndromes 101
defect in the bile acid synthesis and transport in the liver
Ornithine transcarbamylase (OTC) deficiency 101
Ornithine transcarbamylase (OTC) deficiency: most common defect in the Urea cycle in the liver